Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors

American Journal of Pathology

Volumn 155, Issue 4, 1999, Pages 1381-1390

  Jadeski, Lorraine C ^a   Lala, Peeyush K ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 0032850637     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65240-6     Document Type: Article

References (38)

1. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012
2. Knowles RG, Moncada S: Nitric oxide synthases in mammals. Biochem J 1994, 298:249-258
3. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994, 54:1352-1354
4. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995, 72:41-44
5. Dueñas-Gonzalez A, Isales CM, del Mar Abad-Hernandez M, Gonzalez-Sarmiento R, Sangueza O, Rodriguez-Commes J: Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mod Pathol 1997, 10:645-649
6. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA: Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 1995, 55:727-730
7. Thomsen LL, Miles DW: Role of nitric oxide in tumor progression: lessons from human tumors. Cancer Metastasis Rev 1998, 17:107-118
8. Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K: Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 1998, 82:1897-1903
9. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA, Ziche M: Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998, 90:587-596
10. Fujimoto H, Ando Y, Yamashita T, Terazaki H, Tanaka Y, Sasaki J, Matsumoto M, Suga M, Ando M: Nitric oxide synthase activity in human lung cancer. Jpn J Cancer Res 1997, 88:1190-1198
11. Kennovin GD, Hirst DG, Stratford MRL, Flitney FW: Inducible nitric oxide synthase is expressed in tumor-associated vasculature: inhibition retards tumor in vivo. Biology of Nitric Oxide, Part 4: Enzymology, Biochemistry, and Immunology. Edited by S Moncada, M Feelisch, R Busse, EA Higgs, London, Portlant Press, 1994, pp 473-479
12. Edwards P, Cendan JC, Topping DB, Moldawer LL, MacKay S, Copeland EM, Lind DS: Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res 1996, 63:49-52
13. Lala PK, Orucevic A: Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev 1998, 17:91-106
14. G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin-2-induced capillary leakage, and reduces tumor growth in adenocarcinoma-bearing mice. Br J Cancer 1996, 73:189-196
15. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on IL-2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice. Cancer Immunol Immunother 1996, 42:38-46
16. Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR, Lala PK: Nitric oxide production by murine mammary adenocarcinoma cells promotes tumor cell invasiveness. Int J Cancer 1999, 81:889-896
17. Chhatwal VJ, Ngoi SS, Chan ST, Chia YW, Moochhala SM: Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa and surrounding peritumoral normal mucosa. Carcinogenesis 1994, 15:2081-2085
18. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC: Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998, 58:334-341
19. Dong Z, Staroselsky AH, Qi X, Xie K, Fidler IJ: Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 1994, 54:789-793
20. Juang SH, Xie K, Xu L, Shi Q, Wang Y, Yoneda J, Fidler IJ: Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum Gene Ther 1998, 9:845-854
21. Ziche M, Morbidelli L, Masini E, Granger HJ, Geppetti G, Ledda F: Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem Biophys Res Commun 1993, 192:1198-1203
22. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994, 94:2036-2044
23. Konturek SJ, Brzozowski T, Majka J, Pytko-Polonczyk J, Stachura J: Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharmacol 1993, 239:215-217
24. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995, 92:4392-4396
25. Lala PK, Parhar RS: Eradication of spontaneous and experimental adenocarcinoma metastases with chronic indomethacin and intermittent IL-2 therapy. Int J Cancer 1993, 54:677-684
26. Kibbey MC, Grant DS, Kleinman HK: Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J Nat Cancer Inst 1992, 84:1633-1637
27. Folkman J: Tumor angiogenesis: therapeutic applications. N Engl J Med 1971, 285:82-86
28. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8
29. Wiggins DL, Granai CO, Steinhoff MM, Calabresi P: Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol 1995, 56:353-356
30. Brown KJ, Maynes SF, Bezos A, Maguire DJ, Ford MD, Parish CR: A novel in vitro assay for human angiogenesis. Lab Invest 1996, 75: 539-555
31. Auerbach R, Auerbach W, Polakowski I: Assays for angiogenesis: a review. Pharmacol Ther 1991, 51:1-11
32. Leighton J: Invasion and metastasis of heterologous tumors in the chick embryo. Prog Exp Tumor Res 1964, 4:98-125
33. Vu MT, Smith CF, Burger PC, Klintworth GK: An evaluation of methods to quantitate the chick chorioallantoic membrane assay in angiogenesis. Lab Invest 1985, 53:499-508
34. Papapetropoulos A, Desai KM, Rudic RD, Mayer B, Zhang R, Ruiz-Torres MP, Garcia-Cardeña G, Madri JA, Sessa WC: Nitric oxide synthase inhibitors attenuate transforming-growth-factor-β1-stimulated capillary organization in vitro. Am J Pathol 1997, 150:1835-1844
35. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor-induced angiogenesis. J Clin Invest 1997, 99:2625-2634
36. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM: Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998, 101:2567-2578
37. Hood J, Granger HJ: Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem 1998, 273:23504-23508
38. Frank S, Stallmeyer B, Kampfer H, Schaffner C, Pfeilschifter J: Differential regulation of vascular endothelial growth factor and its receptor fms-like tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells. Biochem J 1999, 338:367-374